Approval · Notice of Compliance 22192 · 2019
DATSCAN: Notice of Compliance 22192
Issued May 24, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22192
- Date
- May 24, 2019
- Company
- Ge Healthcare Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DATSCAN | Not yet assigned | — |
Medicinal ingredients
- IOFLUPANE (123I) 74 MBQ per ML